Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 62015TO0718(03)

    Rectification order of 27 April 2018.
    PTC Therapeutics International Ltd v European Medicines Agency.
    Rectification.
    Case T-718/15.

    Court reports – general

    ECLI identifier: ECLI:EU:T:2018:257

    ORDER OF THE GENERAL COURT (Second Chamber)

    27 April 2018 ( *1 )

    (Rectification)

    In Case T‑718/15,

    PTC Therapeutics International Ltd, established in Dublin (Ireland), represented initially by C. Thomas, Barrister, G. Castle, B. Kelly, H. Billson, Solicitors, and M. Demetriou QC, and subsequently by C. Thomas, M. Demetriou, G. Castle and B. Kelly,

    applicant,

    supported by

    European Confederation of Pharmaceutical Entrepreneurs (Eucope), represented by D. Scannell, Barrister, and S. Cowlishaw, Solicitor,

    intervener,

    European Medicines Agency (EMA), represented by T. Jablónski, A. Spina, S. Marino, A. Rusanov and N. Rampal Olmedo, acting as Agents,

    defendant,

    ACTION under Article 263 TFEU for the annulment of Decision EMA/722323/2015 of the EMA of 25 November 2015, granting to a third party, pursuant to Regulation (EC) No 1049/2001 of the European Parliament and of the Council of 30 May 2001 regarding public access to European Parliament, Council and Commission documents (OJ 2001 L 145, p. 43), access to a document containing information submitted in the context of an application for marketing authorisation for the medicinal product Translarna,

    THE GENERAL COURT (Second Chamber),

    composed of M. Prek, President, F. Schalin (Rapporteur) and M. J. Costeira, Judges,

    Registrar: E. Coulon,

    makes the following

    Order

    1

    The Court delivered a judgment on 5 February 2018.

    2

    In accordance with Article 164(1) of the Rules of Procedure of the General Court, it is necessary to rectify, in the version in the language of the case, clerical mistakes or errors in calculation or obvious inaccuracies found in paragraph 51 of that judgment.
     

    On those grounds,

    THE GENERAL COURT (Second Chamber)

    hereby orders:
     

    In paragraph 51 of the judgment, in the version in the language of the case, ‘… as was noted in paragraph 49 above, …’ must be read instead of ‘…as was noted in paragraph Error!Reference source not found. above,…’.

     

    Luxembourg, 27 April 2018

    E. Coulon

    Registrar

    M. Prek

    President

    ( *1 ) Language of the case: English.

    Top